Sun, August 15, 2021
Fri, August 13, 2021
Thu, August 12, 2021

Jeffrey Hung Downgraded (APRE) to Sell and Decreased Target to $60 on, Aug 13th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-60-on-aug-13th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Jeffrey Hung of Morgan Stanley, Downgraded "Aprea Therapeutics, Inc." (APRE) to Sell and Decreased Target from $100 to $60 on, Aug 13th, 2021.

Jeffrey, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30